Memantine-Derived Schiff Bases as Transdermal Prodrug Candidates.

Condensation reactions of salicylaldehyde, 2-pyridinecarboxaldehyde, and pyridoxaldehyde with memantine ( Me ) produced novel memantine-derived Schiff bases ( 1 - 3 ). Speciation predictions and calculations of Log P, Log D, and of the percentage (%) of neutral species for ( 1 - 3 ) were carried out. In comparison with Me , the Schiff bases presented increased log P and log D in all cases and pH values, suggesting higher hydrophobicity. The determined solubilities in n -octanol were 34.7 mg/mL for memantine hydrochloride and 67.3 mg/mL for ( 3 ). According to the molecular weights and calculated logP, compounds ( 1 - 3 ) are suitable for transdermal administration, especially compound ( 3 ). In addition, hydrolysis of 3 with the release of pyridoxal, a daily cofactor in human metabolism, was observed. The results suggested that 3 is the most promising compound and that formation of the pyridoxal Schiff base with Me might be an effective strategy to obtain a prodrug candidate with increased lipophilicity, which would be able to passively cross biological barriers during transdermal delivery and might have applications in the treatment of Alzheimer's disease and other neurological disorders.